Consolidated Balance Sheets
2011 Annual Report
December 31, |
||
(In millions, except per share data) | 2011 |
2010 |
Assets |
||
Current assets: |
||
Cash and cash equivalents |
$2,201.6 | $1,788.8 |
Investments available-for-sale, at fair value: |
|
|
Fixed maturity securities (amortized cost of $15,233.6 and $15,545.4) |
15,913.1 | 16,069.5 |
Equity securities (cost of $937.7 and $861.4) |
1,188.1 | 1,236.2 |
Other invested assets, current |
14.8 | 21.1 |
Accrued investment income |
172.0 | 177.4 |
Premium and self-funded receivables |
3,402.9 | 3,041.6 |
Other receivables |
943.9 | 878.6 |
Income taxes receivable |
105.8 | 32.3 |
Securities lending collateral |
871.4 | 900.3 |
Deferred tax assets, net |
424.8 | 460.9 |
Other current assets |
1,859.0 | 1,534.1 |
Total current assets |
27,097.4 | 26,140.8 |
Long-term investments available-for-sale, at fair value: |
||
Fixed maturity securities (amortized cost of $240.8 and $215.8) |
246.8 | 221.8 |
Equity securities (cost of $28.4 and $32.8) |
28.8 | 33.4 |
Other invested assets, long-term |
1,003.7 | 865.4 |
Property and equipment, net |
1,418.1 | 1,155.5 |
Goodwill |
13,858.7 | 13,264.9 |
Other intangible assets |
7,931.7 | 7,996.8 |
Other noncurrent assets |
433.6 | 488.3 |
Total assets |
$52,018.8 |
$50,166.9 |
|
|
|
Liabilities and shareholders’ equity |
|
|
Liabilities |
|
|
Current liabilities: |
|
|
Policy liabilities: |
|
|
Medical claims payable |
$5,489.0 |
$4,852.4 |
Reserves for future policy benefits |
55.1 |
56.4 |
Other policyholder liabilities |
2,278.2 |
1,909.1 |
Total policy liabilities |
7,822.3 |
6,817.9 |
Unearned income |
926.5 |
891.4 |
Accounts payable and accrued expenses |
3,124.1 |
2,942.2 |
Security trades pending payable |
51.7 |
33.3 |
Securities lending payable |
872.5 |
901.5 |
Short-term borrowings |
100.0 |
100.0 |
Current portion of long-term debt |
1,274.5 |
705.9 |
Other current liabilities |
1,654.1 |
1,617.3 |
Total current liabilities |
15,825.7 |
14,009.5 |
Long-term debt, less current portion |
8,420.9 |
8,147.8 |
Reserves for future policy benefits, noncurrent |
730.7 |
646.7 |
Deferred tax liabilities, net |
2,724.0 |
2,586.9 |
Other noncurrent liabilities |
1,029.3 |
963.4 |
Total liabilities |
28,730.6 |
26,354.3 |
Commitments and contingencies—Note 14 |
|
|
Shareholders’ equity |
|
|
Preferred stock, without par value, shares authorized—100,000,000; |
|
|
shares issued and outstanding—none |
— |
— |
Common stock, par value $0.01, shares authorized—900,000,000; |
|
|
shares issued and outstanding: 339,372,680 and 377,736,929 |
3.4 |
3.8 |
Additional paid-in capital |
11,679.2 |
12,862.6 |
Retained earnings |
11,490.7 |
10,721.6 |
Accumulated other comprehensive income |
114.9 |
224.6 |
Total shareholders’ equity |
23,288.2 |
23,812.6 |
|
|
|
Total liabilities and shareholders’ equity |
$52,018.8 |
$50,166.9 |
The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in WellPoint’s 2011 Annual Report on Form 10-K.